Long- Term Transcranial Direct Current Stimulation in Parkinson's Disease
Long-Term Transcranial Direct Current Stimulation in Parkinson's Disease
1 other identifier
interventional
40
1 country
1
Brief Summary
The goal of the proposed research is to determine the influence of transcranial direct current stimulation (tDCS) on long-term motor learning, transfer of motor learning, and cortical function in Parkinson's disease (PD). The project comprises a 2 week training study that will involve tDCS applied during two practice motor tasks with behavioral, clinical, and physiological evaluations at baseline as well as 1, 14 and 28 days following the 2 week training and stimulation period. The findings of the proposed studies should have significant clinical significance and applications to comprehensive intervention therapy development in the treatment of PD.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for phase_2 parkinson-disease
Started Jul 2018
Typical duration for phase_2 parkinson-disease
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 30, 2018
CompletedFirst Submitted
Initial submission to the registry
August 16, 2018
CompletedFirst Posted
Study publicly available on registry
August 20, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2020
CompletedOctober 19, 2018
October 1, 2018
1.9 years
August 16, 2018
October 18, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Force error in the precision grip task
Changes in force error after the two week intervention
Baseline, 1 day post, 2 weeks post, 4 weeks post
Handwriting task performance
Changes in stroke amplitude, stroke variability, and writing speed after the two week intervention
Baseline, 1 day post, 2 weeks post, 4 weeks post
Secondary Outcomes (3)
Transfer of motor learning
Baseline, 1 day post, 2 weeks post, 4 weeks post
Transfer of motor learning
Baseline, 1 day post, 2 weeks post, 4 weeks post
Transfer of motor learning
Baseline, 1 day post, 2 weeks post, 4 weeks post
Study Arms (2)
Anodal tDCS
EXPERIMENTALAnodal tDCS will be applied in nine experimental sessions over a 2-week period.
SHAM tDCS
SHAM COMPARATORSHAM tDCS will be applied in nine experimental sessions over a 2-week period.
Interventions
Anodal tDCS will be applied over the FDI muscle representational area of the motor cortex for 25 minutes in combination with the two motor tasks (precision grip task and handwriting task).
SHAM tDCS will be applied over the FDI muscle representational area of the motor cortex for 25 minutes in combination with the two motor tasks (precision grip task and handwriting task).
Eligibility Criteria
You may qualify if:
- Able to provide informed consent.
- A clinical diagnosis of idiopathic PD.
- A stable and optimal medical regimen of anti-parkinsonian drug therapy for the duration of the study.
- Modified Hoehn and Yahr stage between 1.0 and 3.0 in the OFF state.
- Right-hand dominant and primarily right-side affected to prevent confounds due to handedness and affected side.
You may not qualify if:
- An uncontrolled medical condition (i.e. hypertension, diabetes, etc).
- Evidence of secondary or atypical parkinsonism as suggested by:
- History of CVA's, exposure to toxins, neuroleptics or encephalitis.
- Neurologic signs of upper motor neuron or cerebellar involvement, supranuclear gaze palsy or significant orthostatic hypertension.
- Metal in the skull or the eye, such as a cardiac pacemaker, brain stimulator, shrapnel, surgical metal, clips in the brain, cochlear implants, and metal fragments in the eye, as these may make TMS and tDCS unsafe.
- An uncertainty about the presence of metal objects in a subject's body exists.
- Hearing loss, have had a brain tumor, a stroke, head trauma, epilepsy or a history of seizures, have another neurological disorder other than a movement disorder, or have a head injury where they passed out for more than a few seconds.
- Pregnant or thought to be pregnant.
- Irrepressible dyskinesia or tremor to prevent the confound of excessive EMG during TMS testing at rest.
- Any other neurological disorders.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Bigelow Health Sciences
Las Vegas, Nevada, 89154-3034, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Brach Poston, Ph.D.
University of Nevada, Las Vegas
Study Design
- Study Type
- interventional
- Phase
- phase 2
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
August 16, 2018
First Posted
August 20, 2018
Study Start
July 30, 2018
Primary Completion
June 30, 2020
Study Completion
December 31, 2020
Last Updated
October 19, 2018
Record last verified: 2018-10